Cargando…
NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma
Biomarker-driven targeted therapies are lacking for head and neck squamous cell carcinoma (HNSCC), which is common and lethal. Efforts to develop such therapies are hindered by a genomic landscape dominated by the loss of tumor suppressor function, including NOTCH1 that is frequently mutated in HNSC...
Autores principales: | Shah, Pooja A., Huang, Chenfei, Li, Qiuli, Kazi, Sawad A., Byers, Lauren A., Wang, Jing, Johnson, Faye M., Frederick, Mitchell J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764697/ https://www.ncbi.nlm.nih.gov/pubmed/33322834 http://dx.doi.org/10.3390/cells9122677 |
Ejemplares similares
-
High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung
por: Frederick, Mitchell, et al.
Publicado: (2020) -
Multifactorial Contribution of Notch Signaling in Head and Neck Squamous Cell Carcinoma
por: Porcheri, Cristina, et al.
Publicado: (2019) -
Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Ghosh, Soma, et al.
Publicado: (2022) -
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer
por: Johnson, Faye M, et al.
Publicado: (2022) -
Evaluation of the anticancer activity of RIN-1, a Notch signaling modulator, in head and neck squamous cell carcinoma
por: Czerwonka, Arkadiusz, et al.
Publicado: (2023)